Literature DB >> 7831420

Discriminative stimulus properties of a new anxiolytic, DN-2327, in rats.

T Wada1, N Fukuda.   

Abstract

In an operant learning lever-pressing procedure on an FR10 schedule of milk reinforcement, male Wistar rats were trained to discriminate between saline and 3 mg/kg IP DN-2327, a new anxiolytic which acts on benzodiazepine receptors, 3 mg/kg IP diazepam or 15 mg/kg IP pentylenetetrazol (PTZ). More than 80% appropriate lever responding was established after 27, 38 and 44 daily training sessions with DN-2327, diazepam and PTZ, respectively, as the training drug. Although rats trained with DN-2327 dose-dependently generalized to various doses of DN-2327 and diazepam, the cue of DN-2327 was more potent than that of diazepam: ED50 values of DN-2327 and diazepam for stimulus generalization were 0.30 and 0.66 mg/kg, respectively. These animals partially generalized to pentobarbital (1-10 mg/kg) but did not generalize to buspirone (0.1-10 mg/kg). Rats trained with diazepam dose-dependently generalized to various doses of DN-2327, diazepam and pentobarbital with ED50 values of 0.51, 0.47 and 4.5 mg/kg, respectively, but did not generalize to buspirone. In rats trained with PTZ, DN-2327 and diazepam antagonized the discriminative stimulus produced by 15 mg/kg PTZ in a dose-dependent manner with ED50 values of 0.27 and 0.83 mg/kg, respectively, but buspirone neither antagonized nor was able to substitute for the PTZ-induced stimulus. The cue of DN-2327 was antagonized by flumazenil dose-dependently as was that of diazepam.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7831420     DOI: 10.1007/bf02251282

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

1.  Discriminative stimulus properties of benzodiazepines, barbiturates and pharmacologically related drugs; relation to some intrinsic and anticonvulsant effects.

Authors:  F C Colpaert; L K Desmedt; P A Janssen
Journal:  Eur J Pharmacol       Date:  1976-05       Impact factor: 4.432

2.  Discriminable effects of benzodiazepines.

Authors:  D A Overton
Journal:  Psychopharmacol Commun       Date:  1976

3.  CGS8216 noncompetitively antagonizes the discriminative effects of diazepam in rats.

Authors:  H E Shannon; S L Davis
Journal:  Life Sci       Date:  1984-06-25       Impact factor: 5.037

4.  Discriminative stimulus properties of chlordiazepoxide and zolpidem. Agonist and antagonist effects of CGS 9896 and ZK 91296.

Authors:  D J Sanger; B Zivkovic
Journal:  Neuropharmacology       Date:  1987-05       Impact factor: 5.250

5.  Pharmacologic profile of a new anxiolytic, DN-2327: effect of Ro15-1788 and interaction with diazepam in rodents.

Authors:  T Wada; N Fukuda
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites.

Authors:  A L Johnston; S E File
Journal:  Pharmacol Biochem Behav       Date:  1989-01       Impact factor: 3.533

7.  Midazolam cue in rats: generalization tests with anxiolytic and other drugs.

Authors:  H S Garcha; I C Rose; I P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

9.  Effect of a new anxiolytic, DN-2327, on learning and memory in rats.

Authors:  T Wada; N Fukuda
Journal:  Pharmacol Biochem Behav       Date:  1992-03       Impact factor: 3.533

Review 10.  Behavioral analogues of anxiety. Animal models.

Authors:  H Lal; M W Emmett-Oglesby
Journal:  Neuropharmacology       Date:  1983-12       Impact factor: 5.250

View more
  1 in total

1.  Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats.

Authors:  Keith L Shelton; Elizabeth S Hendrick; Patrick M Beardsley
Journal:  Drug Alcohol Depend       Date:  2013-01-29       Impact factor: 4.492

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.